BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1832158)

  • 21. Analysis of recognition in the alternative pathway of complement. Effect of polysaccharide size.
    Pangburn MK
    J Immunol; 1989 Apr; 142(8):2766-70. PubMed ID: 2467939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a heparin binding domain in the seventh short consensus repeat of complement factor H.
    Blackmore TK; Sadlon TA; Ward HM; Lublin DM; Gordon DL
    J Immunol; 1996 Dec; 157(12):5422-7. PubMed ID: 8955190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human complement factor H: isolation of cDNA clones and partial cDNA sequence of the 38-kDa tryptic fragment containing the binding site for C3b.
    Schulz TF; Schwäble W; Stanley KK; Weiss E; Dierich MP
    Eur J Immunol; 1986 Nov; 16(11):1351-5. PubMed ID: 2946589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of human factor I and C3b receptor in the cleavage of surface-bound C3bi molecules.
    Medicus RG; Melamed J; Arnaout MA
    Eur J Immunol; 1983 Jun; 13(6):465-70. PubMed ID: 6222909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural characterization of factor I mediated cleavage of the third component of complement.
    Davis AE; Harrison RA
    Biochemistry; 1982 Nov; 21(23):5745-9. PubMed ID: 6217832
    [No Abstract]   [Full Text] [Related]  

  • 26. Mapping of the sites responsible for factor I-cofactor activity for cleavage of C3b and C4b on human C4b-binding protein (C4bp) by deletion mutagenesis.
    Fukui A; Yuasa-Nakagawa T; Murakami Y; Funami K; Kishi N; Matsuda T; Fujita T; Seya T; Nagasawa S
    J Biochem; 2002 Nov; 132(5):719-28. PubMed ID: 12417021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pinpointing the putative heparin/sialic acid-binding residues in the 'sushi' domain 7 of factor H: a molecular modeling study.
    Ranganathan S; Male DA; Ormsby RJ; Giannakis E; Gordon DL
    Pac Symp Biocomput; 2000; ():155-67. PubMed ID: 10902165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mapping the Complement Factor H-Related Protein 1 (CFHR1):C3b/C3d Interactions.
    Hannan JP; Laskowski J; Thurman JM; Hageman GS; Holers VM
    PLoS One; 2016; 11(11):e0166200. PubMed ID: 27814381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Staphylococcal Ecb protein and host complement regulator factor H enhance functions of each other in bacterial immune evasion.
    Amdahl H; Jongerius I; Meri T; Pasanen T; Hyvärinen S; Haapasalo K; van Strijp JA; Rooijakkers SH; Jokiranta TS
    J Immunol; 2013 Aug; 191(4):1775-84. PubMed ID: 23863906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis.
    Klickstein LB; Bartow TJ; Miletic V; Rabson LD; Smith JA; Fearon DT
    J Exp Med; 1988 Nov; 168(5):1699-717. PubMed ID: 2972794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of cell-surface heparin/heparan sulfate-binding proteins of a human uterine epithelial cell line (RL95).
    Raboudi N; Julian J; Rohde LH; Carson DD
    J Biol Chem; 1992 Jun; 267(17):11930-9. PubMed ID: 1601862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phagocytosis by human monocytes of particles activating the alternative pathway of complement.
    Johnson E; Eskeland T; Bertheussen K
    Scand J Immunol; 1984 Jan; 19(1):31-9. PubMed ID: 6701471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional properties of complement factor H-related proteins FHR-3 and FHR-4: binding to the C3d region of C3b and differential regulation by heparin.
    Hellwage J; Jokiranta TS; Koistinen V; Vaarala O; Meri S; Zipfel PF
    FEBS Lett; 1999 Dec; 462(3):345-52. PubMed ID: 10622723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of trypsinization on the activity of human factor H.
    Hong K; Kinoshita T; Dohi Y; Inoue K
    J Immunol; 1982 Aug; 129(2):647-52. PubMed ID: 6211491
    [No Abstract]   [Full Text] [Related]  

  • 35. Structure of vaccinia complement protein in complex with heparin and potential implications for complement regulation.
    Ganesh VK; Smith SA; Kotwal GJ; Murthy KH
    Proc Natl Acad Sci U S A; 2004 Jun; 101(24):8924-9. PubMed ID: 15178763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinetic analysis of glycoprotein C of herpes simplex virus types 1 and 2 binding to heparin, heparan sulfate, and complement component C3b.
    Rux AH; Lou H; Lambris JD; Friedman HM; Eisenberg RJ; Cohen GH
    Virology; 2002 Mar; 294(2):324-32. PubMed ID: 12009874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular modelling of the C-terminal domains of factor H of human complement: a correlation between haemolytic uraemic syndrome and a predicted heparin binding site.
    Perkins SJ; Goodship TH
    J Mol Biol; 2002 Feb; 316(2):217-24. PubMed ID: 11851332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disturbed sialic acid recognition on endothelial cells and platelets in complement attack causes atypical hemolytic uremic syndrome.
    Hyvärinen S; Meri S; Jokiranta TS
    Blood; 2016 Jun; 127(22):2701-10. PubMed ID: 27006390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Demonstration of factor H-like protein 1 binding to Treponema denticola, a pathogen associated with periodontal disease in humans.
    McDowell JV; Lankford J; Stamm L; Sadlon T; Gordon DL; Marconi RT
    Infect Immun; 2005 Nov; 73(11):7126-32. PubMed ID: 16239506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The yeast Candida albicans binds complement regulators factor H and FHL-1.
    Meri T; Hartmann A; Lenk D; Eck R; Würzner R; Hellwage J; Meri S; Zipfel PF
    Infect Immun; 2002 Sep; 70(9):5185-92. PubMed ID: 12183569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.